CL2011002923A1 - Cepa de mycoplasma hyopneumoniae; composicion de vacuna que la comprende; metodo de preparacion; y su uso para prevenir una enfermedad causada por mycoplasma hyopneumoniae en un animal porcino. - Google Patents
Cepa de mycoplasma hyopneumoniae; composicion de vacuna que la comprende; metodo de preparacion; y su uso para prevenir una enfermedad causada por mycoplasma hyopneumoniae en un animal porcino.Info
- Publication number
- CL2011002923A1 CL2011002923A1 CL2011002923A CL2011002923A CL2011002923A1 CL 2011002923 A1 CL2011002923 A1 CL 2011002923A1 CL 2011002923 A CL2011002923 A CL 2011002923A CL 2011002923 A CL2011002923 A CL 2011002923A CL 2011002923 A1 CL2011002923 A1 CL 2011002923A1
- Authority
- CL
- Chile
- Prior art keywords
- mycoplasma hyopneumoniae
- strain
- preparation
- prevent
- vaccine composition
- Prior art date
Links
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 241000282898 Sus scrofa Species 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 238000005259 measurement Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/35—Mycoplasma
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/87—Mycoplasma
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2009902255A AU2009902255A0 (en) | 2009-05-19 | Bacterial strain, vaccine and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2011002923A1 true CL2011002923A1 (es) | 2012-08-31 |
Family
ID=43125658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2011002923A CL2011002923A1 (es) | 2009-05-19 | 2011-11-18 | Cepa de mycoplasma hyopneumoniae; composicion de vacuna que la comprende; metodo de preparacion; y su uso para prevenir una enfermedad causada por mycoplasma hyopneumoniae en un animal porcino. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8524252B2 (enExample) |
| EP (1) | EP2453913B1 (enExample) |
| JP (1) | JP5744852B2 (enExample) |
| KR (1) | KR101734590B1 (enExample) |
| CN (1) | CN102458462B (enExample) |
| AU (1) | AU2010251761B2 (enExample) |
| BR (1) | BRPI1010679B1 (enExample) |
| CA (1) | CA2762587C (enExample) |
| CL (1) | CL2011002923A1 (enExample) |
| DK (1) | DK2453913T3 (enExample) |
| EA (1) | EA021102B1 (enExample) |
| ES (1) | ES2579935T3 (enExample) |
| MX (1) | MX2011012362A (enExample) |
| NZ (1) | NZ596722A (enExample) |
| PE (1) | PE20120909A1 (enExample) |
| WO (1) | WO2010132932A1 (enExample) |
| ZA (1) | ZA201109185B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9260691B2 (en) | 2010-05-19 | 2016-02-16 | Bioproperties Pty Ltd | Methods relating to an attenuated mycoplasma |
| CN104685057B (zh) * | 2012-07-10 | 2019-04-16 | 海博莱科学有限公司 | 用于转化猪肺炎支原体的载体，转化的猪肺炎支原体菌株及其用途 |
| EP2684959A1 (en) * | 2012-07-10 | 2014-01-15 | Laboratorios Hipra, S.A. | Vectors for transforming Mycoplasma hyopneumoniae, transformed M.hyopneumoniae strains, and use thereof |
| UA121193C2 (uk) | 2012-12-28 | 2020-04-27 | Бьорінгер Інгельхайм Ветмедіка Гмбх | Спосіб одержання імуногенної композиції проти мікоплазми |
| US9878027B2 (en) | 2012-12-28 | 2018-01-30 | Boehringer Ingelheim Vetmedica Gmbh | Immunogenic composition comprising mycoplasma antigens |
| EP2913947B1 (en) * | 2014-02-27 | 2019-11-27 | ADVA Optical Networking SE | Passive optical network and optical line terminal |
| KR20160099223A (ko) * | 2015-02-12 | 2016-08-22 | 강원대학교산학협력단 | 마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법 |
| US10071149B2 (en) | 2016-05-03 | 2018-09-11 | Brigham Young University | Temperature sensitive multivalent Bordetella avium vaccines |
| CN113278575B (zh) * | 2021-07-13 | 2021-12-31 | 南华大学 | 一种肺炎支原体减毒突变株及应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPN178995A0 (en) * | 1995-03-16 | 1995-04-13 | University Of Melbourne, The | Antigen composition |
| CN1100871C (zh) * | 1999-06-25 | 2003-02-05 | 江苏省农业科学院畜牧兽医研究所 | 猪肺炎支原体克隆致弱株 |
| US6673567B2 (en) * | 2000-03-23 | 2004-01-06 | E. I. Du Pont De Nemours And Company | Method of determination of gene function |
| US6585981B1 (en) * | 2000-07-27 | 2003-07-01 | Regents Of The University Of Minnesota | Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae |
| MY129765A (en) * | 2000-12-19 | 2007-04-30 | Wyeth Corp | Improved mycoplasma hyopneumoniae bacterin vaccine |
| WO2003004051A2 (en) * | 2001-07-02 | 2003-01-16 | Pfizer Products Inc. | Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle |
| US7691368B2 (en) * | 2005-04-15 | 2010-04-06 | Merial Limited | Vaccine formulations |
| MX2008011247A (es) * | 2006-03-03 | 2008-09-11 | Merial Ltd | Vacuna de micoplasma hyopneumoniae. |
| ME01000B (me) * | 2007-11-06 | 2012-10-20 | Zoetis Services Llc | Živa vakcina avirulentne mycoplasma hyopneumoniae sa adjuvansom |
| CN107213461B (zh) * | 2009-09-10 | 2022-03-15 | 勃林格殷格翰动物保健美国公司 | 包含含有皂苷的佐剂的新疫苗制剂 |
| US9324223B2 (en) | 2012-06-08 | 2016-04-26 | 3M Innovative Properties Company | Electronic monitoring home unit and installation methods |
-
2010
- 2010-05-19 NZ NZ596722A patent/NZ596722A/xx unknown
- 2010-05-19 DK DK10777221.2T patent/DK2453913T3/en active
- 2010-05-19 US US13/321,662 patent/US8524252B2/en active Active
- 2010-05-19 KR KR1020117030155A patent/KR101734590B1/ko active Active
- 2010-05-19 EP EP10777221.2A patent/EP2453913B1/en active Active
- 2010-05-19 JP JP2012511093A patent/JP5744852B2/ja active Active
- 2010-05-19 CN CN201080031403.2A patent/CN102458462B/zh active Active
- 2010-05-19 WO PCT/AU2010/000590 patent/WO2010132932A1/en not_active Ceased
- 2010-05-19 ES ES10777221.2T patent/ES2579935T3/es active Active
- 2010-05-19 PE PE2011001988A patent/PE20120909A1/es not_active Application Discontinuation
- 2010-05-19 MX MX2011012362A patent/MX2011012362A/es active IP Right Grant
- 2010-05-19 AU AU2010251761A patent/AU2010251761B2/en active Active
- 2010-05-19 EA EA201190311A patent/EA021102B1/ru not_active IP Right Cessation
- 2010-05-19 CA CA2762587A patent/CA2762587C/en active Active
- 2010-05-19 BR BRPI1010679-0A patent/BRPI1010679B1/pt active IP Right Grant
-
2011
- 2011-11-18 CL CL2011002923A patent/CL2011002923A1/es unknown
- 2011-12-13 ZA ZA2011/09185A patent/ZA201109185B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2762587A1 (en) | 2010-11-25 |
| PE20120909A1 (es) | 2012-08-19 |
| AU2010251761A1 (en) | 2011-12-22 |
| DK2453913T3 (en) | 2016-07-25 |
| ZA201109185B (en) | 2012-09-26 |
| KR101734590B1 (ko) | 2017-05-11 |
| BRPI1010679B1 (pt) | 2020-09-24 |
| EP2453913B1 (en) | 2016-06-22 |
| US20120135040A1 (en) | 2012-05-31 |
| US8524252B2 (en) | 2013-09-03 |
| KR20120016282A (ko) | 2012-02-23 |
| NZ596722A (en) | 2013-08-30 |
| EP2453913A1 (en) | 2012-05-23 |
| EP2453913A4 (en) | 2013-10-30 |
| EA021102B1 (ru) | 2015-04-30 |
| CN102458462B (zh) | 2014-03-19 |
| AU2010251761B2 (en) | 2014-10-09 |
| WO2010132932A1 (en) | 2010-11-25 |
| CN102458462A (zh) | 2012-05-16 |
| JP5744852B2 (ja) | 2015-07-08 |
| ES2579935T3 (es) | 2016-08-17 |
| JP2012527218A (ja) | 2012-11-08 |
| MX2011012362A (es) | 2012-04-19 |
| EA201190311A1 (ru) | 2012-06-29 |
| CA2762587C (en) | 2017-11-28 |
| BRPI1010679A2 (pt) | 2017-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2011002923A1 (es) | Cepa de mycoplasma hyopneumoniae; composicion de vacuna que la comprende; metodo de preparacion; y su uso para prevenir una enfermedad causada por mycoplasma hyopneumoniae en un animal porcino. | |
| Bergström et al. | Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs | |
| MX2013010343A (es) | Composicion y metodos para el transplante de microbiota de colon. | |
| BR112013003862A2 (pt) | composição removedora de ferrugem | |
| CR10654A (es) | Agentes que comprenden compuestos marcados con 18f y metodos relacionados | |
| UY32456A (es) | Composicion famaceutica, forma farmaceutica, procedimiento para su preparación, metodos de tratamiento | |
| ECSP11011344A (es) | Nuevos anticuerpos anti-?5?1 y sus usos | |
| BR112012004806B8 (pt) | composições imunogênicas que incluem moduladores da atividade de tlr, método para aumento da eficácia da referida composição e uso | |
| UY32923A (es) | Compuestos policíclicos como antagonistas del receptor de ácido lisofosfatídico | |
| AR060565A1 (es) | Vacuna para la gripe aviaria y metodos de uso | |
| JO3257B1 (ar) | مركبات وتركيبات كمعدلات لفاعلية tlr | |
| CR20120264A (es) | Compuestos | |
| UY30820A1 (es) | Uso de agonistas del receptor de glp-1 de accion prolongada para mejorar la sensibilidad a la insulina y los perfiles lipidicos | |
| BR112018013011A2 (pt) | composições de alimento para animais de estimação | |
| UY33238A (es) | "Compuestos en calidad de antagonistas de bradiquinina-b1" | |
| UY32225A (es) | Antagonistas de cicloalcano[b]azaindol de los receptores de la prostaglandina d2 | |
| AR099592A1 (es) | Control ajustable de composiciones de cemento de puzolana y cal | |
| MX2018004067A (es) | Extinguidor que contiene nanomaterial conjugado con polimero soluble en agua y su uso. | |
| CL2013001589A1 (es) | Uso de una emulsion que comprende 0,08% en peso o menos de aceite esencial antimicrobiano, goma acacia y agua para proporcionar un efecto antimicrobiano en una composicion acuosa; proceso para mejorar el efecto antimicrobiano de un aceite esencial antimicrobiano; y composicion acuosa que comprende una emulsion antimicrobiana. | |
| IT1397734B1 (it) | Uso di estratti naturali di tannini e non tannini atti a migliorare la fertilita' del suolo e determinare un effetto starter sulle colture, e fitocomplesso di tannini e di non tannini per tale uso. | |
| UY36395A (es) | Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y su uso. | |
| NI201200144A (es) | Anticuerpos humanizados de il - 25 | |
| CO6260091A2 (es) | Derivados de iminopiridina y su uso | |
| CO6640213A2 (es) | Comprimido de desintegración por vía oral que contiene acarbosa | |
| CL2013003093A1 (es) | Composiciones que comprende cation de polihidroxioxoaluminio detectable por rmn; metodo de fabricacion de los mismos; y su uso. |